Brain Mind Center

Neurotransmitters Dopamine

Dopamine circuits are more specific and better organized than NE and serotonin systems. Dopamine neurons are involved in controlling movement, regulating memory, sexual and reward-seeking behaviors and the regulation of pituitary hormones. Increased dopamine activity is associated with schizophrenia.

Decreased dopamine activity in a specific movement controlling circuit originating from cells in the substantia nigra are associated with Parkinson's disease. Slowing of thinking and movement and depression often precede the more obvious movement disorder which characterizes the disease. The main treatment has been to replace the missing dopamine with l-Dopa (levodopa). With time and disease progression, however, dopamine replacement becomes less efficacious and new adverse effects, including the development of motor fluctuations and drug-induced involuntary movements (dyskinesias) emerge.

When dopamine is slightly modified to 6-hydoxy dopamine, it becomes a potent neurotoxin that can kill dopamine producing neurons. The toxicity of 6-hydroxydopamine involves the generation of reactive oxygen radicals, the impairment of mitochondrial function, and enzyme inhibition. Antioxidants, including catalase, vitamin E, and ascorbic acid, provided protection against 6-OHDA-induced toxicity.  

Liao et al suggested that: Formation of 6-hydroxydopamine (6-OHDA) in the striatum following methamphetamine treatment  plays a  role in methamphetamine-induced nigrostriatal dopaminergic toxicity. Inhibiting both monoamine oxidase with pargyline and catechol-O-methyl-transferase with pyrogallol  lead to an accumulation of 6-OHDA in the striatum; this effect was increased by the addition of methamphetamine which is a potent dopamine releaser. 

Dopamine Increased  

Increased dopamine activity in the brain stem will cause unpleasant symptoms suggesting digestive tract problems - nausea, vomiting, hiccups, excessive salivation and a burning tongue. Increased dopamine in the motor circuits will tend to produce odd, involuntary movements, muscle twitching and bizarre posturing. Early signs of increased dopamine activity include agitation with critical, suspicious thinking and depression. Increased sexual drive and antisocial aggression may occur with disordered arousal.

Dopamine and Schizophrenia

All discussions of schizophrenia should begin with the recognition is that the diagnosis is often uncertain and covers a range of disorders that have different causes and different consequences. Few people with the diagnosis escape drug treatment and psychiatrists generally believe that schizophrenics have to take drugs every day for the rest of their lives. This is an irrational belief that obstructs the study of the natural course of the disorder and prevents the discovery of better methods of management. You can argue two ways:

1. Drugs used to treat schizophrenics are wonderful inventions that control the disease and allow patients to live in the community.

2. Antipsychotic drugs are chemical straight-jackets that are toxic and leave patients more disabled than they would have been if no drugs were ever used.

A corollary to argument 2 is that if other solutions were developed for schizophrenics, such as diet revision, nutrient supplementation, and rehabilitation in natural settings, better long-term results may be achieved.

Phenothiazines were the first drug class available to treat schizophrenia. They were called antipsychotics, major tranquilizers, and neuroleptics. Chlorpromazine was the grand-daddy drug and numerous offspring were developed and marketed. These drugs have multiple modes of action and the antipsychotic effect is attributed to dopamine blocking. With long term use, drug-induced Parkinsons disease is a major, disabling adverse effect. Kapur suggests that delusions develop when excessive dopamine release occurs in response to mundane events. Delusions are the stories that patients construct to explain increased salience of common events. Antipsychotic drugs block dopamine-2 neuroreceptors and reduce the salience of ordinary experiences: the patient may say that the government is spying on him, but that it doesn't bother him anymore. Kapur claims that resolution of symptoms occurs within the first week of antipsychotic treatment.

All early antipsychotics inhibit dopamine (DA) neurotransmission by blocking postsynaptic DA receptors. Other neurotransmitter systems, such as those for serotonin (5-HT), glutamate, noradrenaline and acetylcholine, are also implicated, and atypical antipsychotics are also antagonists of serotonin (5-HT) receptors. Blocking DA receptors in some brain regions is also responsible for negative effects such as Parkinsons effects and hormonal changes. 

Further reading: Neuroscience Notes, Intelligence and Learning, Language & Thinking

Persona Digital

Persona Digital Books is the publisher of The Human Brain, Neuroscience Notes, Intelligence & Learning and related books. Three books are available as print editions for mail delivery. All books are available as eBooks for download (PDF files).